Vivimed Labs
VIVIMEDLABNSE

Vivimed Labs

₹6.87-0.10 (1.43%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
6.78
Today’s high
7.00
52 week low
5.15
52 week high
29.40
Open price
7.00
Previous close
6.97
Live volume
81,866
Lower circuit
6.63
Upper circuit
7.31

Fundamentals

Market Cap
₹58Cr
ROE
50.81%
P/E Ratio(TTM)
-1.81
EPS(TTM)
-4.21
P/B Ratio
0.00
Dividend Yield
0.00%
Industry P/E
34.49
Book Value
-10.37
Debt to Equity
-8.01
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹15.99
-23.20%
Profit (Cr)
-₹16.55
-126.71%
-20-501530
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)-56%
3Y CAGR-20%
Profit growthValue
1Y (TTM)-64%
3Y CAGR+28%

About

Vivimed Labs is a diversified pharmaceutical company based in Hyderabad, India, which develops formulations and offers contract manufacturing services to domestic and international clients. The company is committed to continuously enhancing its competitiveness by building strong capabilities in R&D and achieving end-to-end operational excellence. To support its operations, the company runs five certified manufacturing facilities and a dedicated R&D centre focused on pharmaceutical innovation.;
CEO/MD
Shri. Ramesh Krishnamurthy
Founded in
--
NSE symbol
VIVIMEDLAB

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
81.42%
Foreign Institutions
11.01%
Promoters
7.57%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹875.75
+12.10 (1.40%)
L
    H
    4,938.8037.34.84
    ₹398.50
    -0.65 (0.16%)
    L
      H
      4,342.2790.7716.42
      ₹416.35
      -5.15 (1.22%)
      L
        H
        3,939.0043.955.4
        Aarti DrugsAARTIDRUGS
        ₹387.90
        -9.75 (2.45%)
        L
          H
          3,630.2617.932.47
          Livesquawk
          Vivimed Labs' CFO and CS received CBI notice after SBI's financial complaint. The complaint by SBI pertains to alleged financial issues involving Vivimed Labs.
          2026
          13
          Mar
          Quarterly Result
          Release date
          13
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks